| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60b9c44857fe2d9d6716a0eabea0a78e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d26670ec0ec1d57d62c6c7d7faf120e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_501e7dc41daf6361306ecd3e053557bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5994382e9c20c8174b9105b4f9a4a216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ed2331ae0bf5ce538e7d4e1deb3d609 |
| publicationDate |
2019-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190126433-A |
| titleOfInvention |
Oral Delivery of Physiologically Active Substances |
| abstract |
Embodiments may include compositions for oral drug delivery. The composition may comprise a physiologically active substance, a carrier compound, a mucoadhesive compound and a penetration enhancer. The physiologically active substance can be transported through the stomach. The physiologically active substance may be stable and not degraded in harsh gastric acid environments. To help protect the physiologically active substance, the physiologically active substance is mixed with a carrier. The carrier may be a liquid that is insoluble in the stomach acid. The physiologically active substance can be dissolved in the carrier. The mucoadhesive compound may be used to promote adsorption of the physiologically active substance into the stomach. The penetration enhancer may facilitate the transport of the physiologically active material through the stomach wall. |
| priorityDate |
2017-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |